Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.64 |
| ▸ | GNRHR | P30968 | 1/20 | 0.63 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | APLNR | P35414 | 4/20 | 0.60 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30839205 | 0.97 | GNRHR (0.64) | C5AR1GNRHRABCC2PTGS1APLNR | |
| SCHEMBL29425251 | 0.96 | GNRHR (0.64) | C5AR1GNRHRABCC2PTGS1APLNR | |
| SCHEMBL30839204 | 0.96 | GNRHR (0.64) | C5AR1GNRHRABCC2PTGS1APLNR | |
| SCHEMBL30198868 | 0.95 | GNRHR (0.66) | C5AR1GNRHRABCC2PTGS1APLNR | |
| SCHEMBL29425250 | 0.95 | GNRHR (0.70) | C5AR1GNRHRABCC2PTGS1APLNR | |
| SCHEMBL30773556 | 0.94 | PTGS1 (0.71) | C5AR1GNRHRABCC2PTGS1APLNR | |
| SCHEMBL6512254 | 0.94 | PTGS1 (0.71) | C5AR1GNRHRABCC2PTGS1APLNR | |
| SCHEMBL29857994 | 0.93 | GNRHR (0.67) | C5AR1GNRHRABCC2PTGS1APLNR | |
| SCHEMBL31733948 | 0.93 | GNRHR (0.67) | C5AR1GNRHRABCC2PTGS1APLNR | |
| Deslorelin SCHEMBL25353366 | 0.92 | GNRHR (0.74) | C5AR1GNRHRABCC2PTGS1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024210903-A1 | MODIFIED PEPTIDE LIGANDS FOR STABLE DELIVERY OF HIGHLY POTENT PAYLOADS TO TUMORS: METHOD OF MAKING AND USING SAME | LAMHARZI NAJIB (US) | 2024-10-10 | — | — | WO | disclosed |